Intrathecal baclofen therapy using an implantable infusion pump

Alberta Heritage Foundation for Medical Research
Record ID 31998008917
Authors' objectives: The aim of this report is to provide information on the efficacy of intrathecal baclofen therapy using an implantable infusion pump for the treatment of severe spasticity in individuals with multiple sclerosis (MS).
Authors' recommendations: Intrathecal baclofen delivered by infusion pump to control severe spasticity in carefully selected spinal cord injury or multiple sclerosis patients seems to improve the quality of life and can reduce the number of in hospital days. Patients need to be carefully screened and selected to ensure that the appropriate treatment option is being provided. This treatment must be carried out by an experienced team with full facilities for proper preoperative and postoperative assessment.
Authors' methods: Review
Project Status: Completed
Year Published: 1997
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Canada
MeSH Terms
  • Baclofen
  • Multiple Sclerosis
  • Muscle Spasticity
Organisation Name: Institute of Health Economics
Contact Address: 1200, 10405 Jasper Avenue, Edmonton, Alberta, Canada, T5J 3N4. Tel: +1 780 448 4881; Fax: +1 780 448 0018;
Contact Name:
Contact Email:
Copyright: Alberta Heritage Foundation for Medical Research
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.